4 results match your criteria: "University of Miami and Jackson Health System[Affiliation]"
Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report.
Pediatr Neurol
December 2023
Department of Pediatric Neurology, University of Miami and Jackson Health System, Miami, Florida.
Article Synopsis
- Lacosamide is an FDA-approved antiepileptic drug used for treating partial-onset seizures, but it has been associated with potential cardiac side effects, such as PR prolongation and AV block.
- A case study details a three-week-old girl who developed second-degree AV heart block and cardiac arrest after starting lacosamide for seizures, despite having no prior cardiac issues.
- The study suggests that the safety of lacosamide in neonates requires further evaluation, particularly in light of this first reported instance of serious cardiac complications linked to its use.
Valproic Acid Induced Thrombocytopenia and Dysmegakaryopoiesis in a Pediatric Patient.
Ann Clin Lab Sci
September 2022
Department of Pathology and Laboratory Medicine, University of Miami and Jackson Health System, Miami, FL, USA.
Objective: Valproic acid (VPA) is an effective first-line anticonvulsant that is associated with several side effects including bone marrow suppression and subsequent cytopenia. However, VPA associated myelodysplasia is not a well described entity that can be seen in patients on VPA treatment.
Case Report: Herein, we describe a 9-year-old female patient with a past medical history of seizure disorder who presented with 3-week history of intermittent fevers, fatigue, weakness, and multiple unexplained bruises.
Describing IgA Myeloma: An Immunophenotypic and Molecular Approach.
R I Med J (2013)
August 2022
Department of Pathology and Laboratory Medicine, University of Miami and Jackson Health System, Miami, Florida.
Plasma cell myeloma (PCM) is defined as a clonal disease of terminally differentiated plasma cells that secrete immunoglobulin. The biologic underpinnings of IgA-type multiple myeloma's (IgAMM) aggressive nature, including its increased morbidity and mortality, have not been elucidated. We describe the clinical, phenotypic, and cytogenetic characteristics of IgA-MM.
View Article and Find Full Text PDFHorner's syndrome following single lung transplantation.
J Card Surg
January 2020
Department of Surgery, Miami Transplant Institute, University of Miami, Miami, Florida.
Lung transplantation have significantly improved quality of life in patients with end stage respiratory failure, however use of lifelong immunosuppressive therapy and development of bronchiolitis obliterans reflects in a 5-year survival is less the 60%. Ophthalmic complications following lung transplantation are uncommon. Some cases of infectious and malignant ophthalmic complications have been described previously.
View Article and Find Full Text PDF